Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
30
31
1
12:00 AM - TEDMED 2017
2
3
5
6
7
8
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
30
1
2
3
TEDMED 2017
2017-11-01 - 2017-11-03    
All Day
A healthy society is everyone’s business. That’s why TEDMED speakers are thought leaders and accomplished individuals from every sector of society, both inside and outside [...]
AMIA 2017 Annual Symposium
2017-11-04 - 2017-11-08    
All Day
Call for Participation We invite you to contribute your best work for presentation at the AMIA Annual Symposium – the foremost symposium for the science [...]
Beverly Hills Health IT Summit
2017-11-09 - 2017-11-10    
All Day
About Health IT Summits U.S. healthcare is at an inflection point right now, as policy mandates and internal healthcare system reform begin to take hold, [...]
Forbes Healthcare Summit
2017-11-29 - 2017-11-30    
All Day
ForbesLive leverages unique access to the world’s most influential leaders, policy-makers, entrepreneurs, and artists—uniting these global forces to harness their collective knowledge, address today’s critical [...]
Events on 2017-11-01
TEDMED 2017
1 Nov 17
La Quinta
Events on 2017-11-04
AMIA 2017 Annual Symposium
4 Nov 17
WASHINGTON
Events on 2017-11-09
Beverly Hills Health IT Summit
9 Nov 17
Los Angeles
Events on 2017-11-29
Forbes Healthcare Summit
29 Nov 17
New York
Press Releases

Oct 06 : VigiLanz Real-Time Software Helps U.S. Hospitals Identify Ebola Virus

vigilanz

News Summary :

SaaS platform quickly configured to support U.S. hospitals’ preparation for potential virus threat.VigiLanz released new capability in its real-time SaaS platform

“Ebola is not an easy virus for Infection Prevention practitioners to immediately identify to satisfy isolation and reporting protocols and requirements. Since a rapid Ebola test is not currently available, clinicians are required to review a patient’s travel history and combine that information with a multitude of other symptoms to attempt to ascertain those patients that require closer scrutiny for a possible Ebola virus infection,” said Stacy Pur, vice president for clinical decision support at VigiLanz.